Evolent Health
(NYSE) EVH
Evolent Health Financials at a Glance
Market Cap
$649.02M
Revenue (TTM)
$1.89B
Net Income (TTM)
-$496.52M
EPS (TTM)
-$4.76
P/E Ratio
-1.21
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$5.44
Volume
1,374,797.262
Open
$5.46
Price
$5.44
Volume
1,374,797.262
Open
$5.46
Previous Close
$5.77
Daily Range
$5.18 - $5.53
52-Week Range
$2.10 - $12.07
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$5.44
Volume
1,374,797.262
Open
$5.46
Previous Close
$5.77
Daily Range
$5.18 - $5.53
52-Week Range
$2.10 - $12.07
Estimated Earnings Date
Aug 6, 2026
EVH News
EVH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Evolent Health
Industry
Health Care Technology
Sector
Health CareEmployees
4,200
CEO
Seth B. Blackley, MBA
Website
www.evolent.comHeadquarters
Arlington, VA 22203, US
EVH Financials
Key Financial Metrics (TTM)
Gross Margin
14.13%
Operating Margin
-0.86%
Net Income Margin
-26.29%
Return on Equity
-77.89%
Return on Capital
-0.32%
Return on Assets
-26.43%
Earnings Yield
-82.64%
Dividend Yield
0.00%
Payout Ratio
-1.32%
Stock Overview
Market Cap
$649.02M
Shares Outstanding
112.48M
Volume
1.37M
Avg. Volume
2.72M
Financials (TTM)
Gross Profit
$266.94M
Operating Income
-$16.29M
EBITDA
-$314.51M
Operating Cash Flow
$33.29M
Capital Expenditure
-$31.90M
Free Cash Flow
$1.40M
Cash & ST Invst.
$166.01M
Total Debt
$985.43M
Evolent Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$496.25M
+2.6%
Gross Profit
$61.92M
-39.6%
Gross Margin
12.48%
N/A
Market Cap
$649.02M
N/A
Market Cap/Employee
$144.23K
N/A
Employees
4,500
N/A
Net Income
-$26.63M
+58.8%
EBITDA
$13.63M
+147.5%
Quarterly Fundamentals
Total Cash
$166.01M
-32.7%
Total Debt
$985.43M
+13.3%
Accounts Receivable
$314.16M
-27.0%
Inventory
$0.00
N/A
Long Term Debt
$976.65M
+47.3%
Short Term Debt
$8.78M
-95.8%
Return on Assets
-26.43%
N/A
Return on Invested Capital
-1.09%
N/A
Free Cash Flow
-$7.39M
-83.4%
Operating Cash Flow
-$984.00K
-121.6%